Skip to content

Omega-3 Supplementation for Menstrual Pain and Running Performance in Endurance Trained Females

A Randomized, Double-blind, 2-month, Control Trial to Compare the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acids (2g/d total EPA + DHA) Versus Placebo on Menstrual Pain and 5km Running Performance in Endurance Trained Female Athletes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000035325
Enrollment
44
Registered
2026-01-09
Start date
2026-02-02
Completion date
2026-09-07
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Menstrual pain (dysmenorrhoea) affects approximately 70-80% of physically active females and has been associated with reduced exercise performance, exercise participation and quality of life. Common treatments like painkillers (e.g., Panadol, Nurofen) and hormonal contraceptives, are often accompanied with side-effects and are not appropriate for all females. Emerging evidence suggests Omega-3, known for its heart and anti-inflammatory benefits, may also reduce menstrual pain, improve mood, support muscle recovery and improve endurance performance. However, research has yet to test Omega-3 in physically active females and whether the reduction in menstrual cycle symptoms can result in improved endurance performance. This study aims to test whether Omega-3 supplementation can reduce menstrual pain and improve 5km running performance. The study will also investigate the underlying mechanisms (such as changes in menstrual blood biomarkers) and other performance measures like heart rate recovery, running economy, and fuel use during exercise.

Interventions

Intervention: Omega-3 (Fish Oil) Supplementation for Menstrual Pain and Running Performance (Comparator: Placebo, Flaxseed Oil drink) Why: Menstrual pain affects 70–80% of physically active females and is associated with reduced exercise performance. Omega-3 fatty acids (EPA/DHA) may reduce menstrual pain, inflammation, and improve endurance performance, but have not been tested in endurance-trained females. The intervention aims to determine whether daily Omega-3 supplementation for two menst

Intervention: Omega-3 (Fish Oil) Supplementation for Menstrual Pain and Running Performance (Comparator: Placebo, Flaxseed Oil drink) Why: Menstrual pain affects 70–80% of physically active females and is associated with reduced exercise performance. Omega-3 fatty acids (EPA/DHA) may reduce menstrual pain, inflammation, and improve endurance performance, but have not been tested in endurance-trained females. The intervention aims to determine whether daily Omega-3 supplementation for two menstrual cycles reduces menstrual pain and improves 5 km running performance relative to placebo. Materials: Participants receive 200 mL single-serve drinks daily for ~8 weeks (two menstrual cycles). Both the Omega-3 and placebo drinks are manufactured by Smartfish. Omega-3 Drink Composition (per 200 mL) Fruit juice (apple, pear, pomegranate, aronia): 172 g Whey protein: 14 g Fish oil: 10.2 g EPA: 0.8 g DHA: 1.2 g Stabiliser (pectin): 1.2 g Flavour: 0.6 g Malic acid: 0.4 g Tocopherol-rich extract: 0.02 g Vitamin D: 200 µg Placebo Drink Composition (per 200 mL) Identical to the Omega-3 drink except: Rapeseed oil: 10.2 g (no fish oil) 0 g EPA & 0 g DHA Both drinks are similar in appearance, taste, and packaging. Supplementation Procedures: Participants are randomly allocated to Omega-3 or placebo at Visit 3. They take one 200 mL drink daily for ~8 weeks with their evening meal. Compliance is monitored via: - Daily online survey reporting supplement intake - Pre- and post-intervention omega-3 index blood samples Co-intervention Study procedures: Participants also complete: - Daily menstrual cycle symptom monitoring via MCS-MT - Daily ovulation testing for up to 10 days per cycle - Food diaries before testing visits and for 3 days during supplementation - Five laboratory visits including fitness testing, 5 km time trials, anthropometry, blood sampling, and optional menstrual-fluid collection Who Provides the Intervention: - Omega-3 and placebo Drink provided by Smartfish Nutrition - Supplement allocation, physiological testing, and supervision are conducted by trained exercise physiology and nutrition research staff at Deakin University. Delivery of Intervention: - Supplements are self-administered at home once daily. - Lab-based assessments are supervised face-to-face by qualified researchers. Where: - All testing occurs at Deakin University Burwood Campus exercise physiology laboratories. - Supplement ingestion, symptom tracking, and ovulation testing occur at home. When and How much: Dose: 200 mL drink per day (2 g EPA+DHA for the active group). Duration: Two menstrual cycles (~8 weeks). Timing: Taken with the evening meal. Lab visits: 5 visits over ~9 weeks. Laboratory Visits: Visit 1 (Familiarisation): Familiarisation 5km run on a treadmill Visit 2 (Baseline Physiology Testing): Vo2max test, fatmax test, anthropometric measures (weight, height, % body fat) Visit 3 (Pre-supplementation): venous blood sample, finger prick sample, collection of menstrual fluid, 5km run time trial, Quality of Life questionnaire and Menstrual Cycle Symptom Monitoring Tool questionnaire Visit 4 (Repeat Physiology Testing): same as visit 2 Visit 5 (Post-supplementation): same as visit 3 All visits will be approximately an hour long. Timeline: Visit 1: at least 3-5 days before Visit 2 Visit 2: approximately 7 days before period Visit 3: day 2-3 of period (approximately 9-10 days after visit 2) Supplement with omega-3 or placebo daily starting the day after visit 3 for two menstrual cycles until Visit 5 (approximately 8 weeks). Visit 4: approximately 7 days before period (approximately 6.5 weeks after they started supplementing) Visit 5: day 2-3 of period (approximately 8 weeks after they started supplementing and 9-10 days after visit 4). See figure 1 in plain language statement and consent form attached in Step 11.

Sponsors

Deakin University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Participants must be 1) female adults (aged between 18-45 years), 2) naturally menstruating (menstrual cycle regularly 21-35 days, 3) endurance-trained (complete greater than or equal to 2.5h aerobic exercise per week), 4) able to run 5km continuously, 5) have low omega-3 intake (supplementation and oily fish intake less than twice per week), 6) experience menstrual pain (rating greater than 50 out of 100mm on a VAS for menstrual cycles over the previous 6 months), 7) live in Victoria and be willing to travel to Deakin Burwood campus on five occasions.

Exclusion criteria

Participants will be excluded if they 1) self-report as vegetarian or vegan, 2) allergy to fish, sea food, rapeseed, dairy or fruit juice, 3) are regular consumers of shellfish/oily fish (more than once per week over the past 3 months), 4) smokers, 5) BMI higher than 27 kg/m2 or lower than 18.5 kg/m2 6) acute or terminal illness, 7) with a current injury or functional impairment that would limit inclusion in the trial, 8) current chronic disease including cancer, diabetes, cardiovascular disease , chronic liver disease, and gastrointestinal disorders that affects nutrient absorption, 9) Pregnant or breastfeeding, 10) using or ceased using hormonal contraceptives within previous 3 months, 11) known cause of secondary dysmenorrhea e.g., fibroids, endometriosis, adenomyosis, 12) cognitive impairment; or inability to commit to the study and its requirements and be randomised to their experimental group.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026